ArticleEcancermedicalscience2021

Emerging biomarkers in metastatic urothelial carcinoma: tumour mutational burden, PD-L1 expression and APOBEC polypeptide-like signature in a patient with complete response to anti-programmed cell death protein-1 inhibitor.

Marcello Moro Queiroz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.